197 related articles for article (PubMed ID: 28498352)
1. Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice.
Huang PK; Lin SX; Tsai MJ; Leong MK; Lin SR; Kankala RK; Lee CH; Weng CF
Nanomaterials (Basel); 2017 May; 7(5):. PubMed ID: 28498352
[TBL] [Abstract][Full Text] [Related]
2. Polyalthia Clerodane Diterpene Potentiates Hypoglycemia via Inhibition of Dipeptidyl Peptidase 4.
Huang PK; Lin SR; Riyaphan J; Fu YS; Weng CF
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691220
[TBL] [Abstract][Full Text] [Related]
3. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
4. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
[TBL] [Abstract][Full Text] [Related]
5. Biological function of dipeptidyl peptidase-4 on type 2 diabetes patients and diabetic mice.
Qiao J; Li L; Ma Y; Shi R; Teng M
Curr Res Transl Med; 2019 Aug; 67(3):89-92. PubMed ID: 30591375
[TBL] [Abstract][Full Text] [Related]
6. The autophagic inhibition oral squamous cell carcinoma cancer growth of 16-hydroxy-cleroda-3,14-dine-15,16-olide.
Cheng MF; Lin SR; Tseng FJ; Huang YC; Tsai MJ; Fu YS; Weng CF
Oncotarget; 2017 Oct; 8(45):78379-78396. PubMed ID: 29108236
[TBL] [Abstract][Full Text] [Related]
7. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
[TBL] [Abstract][Full Text] [Related]
8. Constitutive increase in active GLP-1 levels by the DPP4 inhibitor ASP4000 on a new meal tolerance test in Zucker fatty rats.
Tanaka-Amino K; Hatakeyama Y; Takakura S; Mutoh S
Pharmacol Res; 2009 Oct; 60(4):264-9. PubMed ID: 19520592
[TBL] [Abstract][Full Text] [Related]
9. Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model.
Shrestha N; Araújo F; Shahbazi MA; Mäkilä E; Gomes MJ; Airavaara M; Kauppinen EI; Raula J; Salonen J; Hirvonen J; Sarmento B; Santos HA
J Control Release; 2016 Jun; 232():113-9. PubMed ID: 27091697
[TBL] [Abstract][Full Text] [Related]
10. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy.
Araújo F; Shrestha N; Gomes MJ; Herranz-Blanco B; Liu D; Hirvonen JJ; Granja PL; Santos HA; Sarmento B
Nanoscale; 2016 May; 8(20):10706-13. PubMed ID: 27150301
[TBL] [Abstract][Full Text] [Related]
11. Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice.
Flock G; Baggio LL; Longuet C; Drucker DJ
Diabetes; 2007 Dec; 56(12):3006-13. PubMed ID: 17717280
[TBL] [Abstract][Full Text] [Related]
12. SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model.
Sim AY; Choi DH; Kim JY; Kim ER; Goh AR; Lee YH; Lee JE
Biomed Pharmacother; 2023 Dec; 168():115755. PubMed ID: 37871560
[TBL] [Abstract][Full Text] [Related]
13. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
[TBL] [Abstract][Full Text] [Related]
14. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
Kim MK; Chae YN; Kim HD; Yang EK; Cho EJ; Choi SH; Cheong YH; Kim HS; Kim HJ; Jo YW; Son MH; Kim SH; Shin CY
Life Sci; 2012 Jan; 90(1-2):21-9. PubMed ID: 22056373
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network meta-analysis of 58 randomized controlled trials.
Ling J; Cheng P; Ge L; Zhang DH; Shi AC; Tian JH; Chen YJ; Li XX; Zhang JY; Yang KH
Acta Diabetol; 2019 Mar; 56(3):249-272. PubMed ID: 30242726
[TBL] [Abstract][Full Text] [Related]
16. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes.
Al-Aissa Z; Rosta K; Hadarits O; Harreiter J; Zóka A; Bancher-Todesca D; Patócs A; Kiss K; Sármán B; Pusztai P; Sziller I; Rigó J; Rácz K; Somogyi A; Kautzky-Willer A; Firneisz G
Eur J Clin Invest; 2015 Feb; 45(2):196-203. PubMed ID: 25556541
[TBL] [Abstract][Full Text] [Related]
17. Self-Regulated Carboxyphenylboronic Acid-Modified Mesoporous Silica Nanoparticles with "Touch Switch" Releasing Property for Insulin Delivery.
Hou L; Zheng Y; Wang Y; Hu Y; Shi J; Liu Q; Zhang H; Zhang Z
ACS Appl Mater Interfaces; 2018 Jul; 10(26):21927-21938. PubMed ID: 29932320
[TBL] [Abstract][Full Text] [Related]
18. Changes in glucose-induced plasma active glucagon-like peptide-1 levels by co-administration of sodium-glucose cotransporter inhibitors with dipeptidyl peptidase-4 inhibitors in rodents.
Oguma T; Kuriyama C; Nakayama K; Matsushita Y; Hikida K; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Minami M; Shiotani M
J Pharmacol Sci; 2016 Dec; 132(4):255-261. PubMed ID: 27889414
[TBL] [Abstract][Full Text] [Related]
19. Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4.
Ohara-Nemoto Y; Nakasato M; Shimoyama Y; Baba TT; Kobayakawa T; Ono T; Yaegashi T; Kimura S; Nemoto TK
Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630069
[TBL] [Abstract][Full Text] [Related]
20. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
